Kyorin Pharmaceutical Co Ltd 4569
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- ¥1,071.00
- Day Range
- ¥1,062.00–1,072.00
- 52-Week Range
- ¥1,046.00–1,725.00
- Bid/Ask
- ¥1,071.00 / ¥1,073.00
- Shares Outstanding
- 57.45M
- Market Cap
- ¥61.52B
- Volume/Avg
- 66,300 / 224,080
Key Statistics
- Price/Earnings (Normalized)
- 31.59
- Price/Sales
- 0.49
- Dividend Yield (Trailing)
- 4.39%
- Dividend Yield (Forward)
- 4.39%
- Dividend Payment Schedule
- Jun, Dec
- Total Yield
- 4.39%
Company Profile
Kyorin Pharmaceutical Co Ltd is engaged in manufacturing and sale of pharmaceutical products. The company manages its business in single reportable segment namely Pharmaceutical Business. The Pharmaceutical business focuses on producing and selling ethical drugs, generic drugs and over-the-counter drugs. The company's products include Kipres, for treating bronchial asthma and allergic rhinitis and others. Majority of the company's revenue comes from domestic sales.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Value
- Total Number of Employees
- 2,226
- Website
- https://www.kyorin-pharm.co.jp
Valuation
|
Metric
|
4569
|
|---|---|
Price/Earnings (Normalized) | 31.59 |
Price/Book Value | 0.44 |
Price/Sales | 0.49 |
Price/Cash Flow | 10.21 |
Price/Earnings
4569
Financial Strength
|
Metric
|
4569
|
|---|---|
Quick Ratio | 2.29 |
Current Ratio | 5.18 |
Interest Coverage | 12.62 |
Quick Ratio
4569
Profitability
|
Metric
|
4569
|
|---|---|
Return on Assets (Normalized) | 1.39% |
Return on Equity (Normalized) | 1.91% |
Return on Invested Capital (Normalized) | 1.47% |
Return on Assets
4569
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Merck KGaA ADR
MKKGY
| LOCK|!lv!@&S | LOCK|G&Z@T | $67B | |||
| Teva Pharmaceutical Industries Ltd
TEVA
| LOCK|sPl?s%@ | LOCK|zm@$ | $48B | |||
| Haleon PLC ADR
HLN
| LOCK|X?$>?hf | LOCK|!^s | $41B | |||
| Zoetis Inc Class A
ZTS
| LOCK|b$&#!fQ | LOCK|CW | $31B | |||
| Viatris Inc
VTRS
| LOCK|p!?&>$ | LOCK|&^d | $20B | |||
| Elanco Animal Health Inc
ELAN
| LOCK|cH | LOCK|Jc@ | $11B | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| LOCK|h##fG< | LOCK|LWm | $11B | |||
| Hims & Hers Health Inc Ordinary Shares - Class A
HIMS
| LOCK|N>w%^Y | LOCK|R! | $7B | |||
| Prestige Consumer Healthcare Inc
PBH
| LOCK|>V?v^T | LOCK|Yy&s | $2B | |||
| Perrigo Co PLC
PRGO
| LOCK|^>!!?n | LOCK|D% | $2B |
United States